Technical Analysis for CUR - Neuralstem, Inc.

Grade Last Price % Change Price Change
grade F 1.52 -16.94% -0.31
CUR closed down 16.94 percent on Thursday, October 31, 2019, on 2.41 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CUR trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Shooting Star Candlestick Bearish -16.94%
Lizard Bearish Bearish Day Trade Setup -16.94%
Crossed Above 20 DMA Bullish -16.94%
Crossed Above 50 DMA Bullish -16.94%
Expansion Pivot Buy Setup Bullish Swing Setup -16.94%
Pocket Pivot Bullish Swing Setup -16.94%

Older signals for CUR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. Its stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons. Its products under development include NSI – 566, which has completed Phase I clinical trial for the proposed treatment of amyotrophic lateral sclerosis, as well as for chronic spinal cord injury and motor deficits due to ischemic stroke; and NSI – 189, a small molecule pharmaceutical compound, which is in Phase Ib clinical trial for the treatment of major depressive disorder. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.
Biotechnology Biopharmaceutical Life Sciences Biology Stem Cells Amyotrophic Lateral Sclerosis Major Depressive Disorder Stem Cell Therapy Treatment Of Major Depressive Disorder Ischemic Stroke
Is CUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.8
52 Week Low 1.1
Average Volume 868,608
200-Day Moving Average 6.2566
50-Day Moving Average 1.5524
20-Day Moving Average 1.336
10-Day Moving Average 1.381
Average True Range 0.2153
ADX 23.88
+DI 39.9482
-DI 17.3493
Chandelier Exit (Long, 3 ATRs ) 1.6341
Chandelier Exit (Short, 3 ATRs ) 1.7459
Upper Bollinger Band 1.6061
Lower Bollinger Band 1.0659
Percent B (%b) 0.84
BandWidth 40.434132
MACD Line -0.0437
MACD Signal Line -0.1053
MACD Histogram 0.0616
Fundamentals Value
Market Cap 18.42 Million
Num Shares 12.1 Million
EPS -2.22
Price-to-Earnings (P/E) Ratio -0.68
Price-to-Sales 977.06
Price-to-Book 2.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.02
Resistance 3 (R3) 2.06 1.93 1.93
Resistance 2 (R2) 1.93 1.81 1.91 1.90
Resistance 1 (R1) 1.73 1.73 1.67 1.69 1.88
Pivot Point 1.60 1.60 1.57 1.58 1.60
Support 1 (S1) 1.40 1.48 1.34 1.36 1.16
Support 2 (S2) 1.27 1.40 1.25 1.14
Support 3 (S3) 1.07 1.27 1.11
Support 4 (S4) 1.03